What is NDC 63323-489?

63323-489 is the product NDC for Xylocaine MPF, Lidocaine hydrochloride anhydrous 20 mg/mL; Epinephrine bitartrate .005 mg/mL injection, solution, listed with the FDA by Fresenius Kabi USA, LLC. It has 3 package NDCs, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Xylocaine MPF (Lidocaine hydrochloride,Epinephrine bitartrate).

What is the active ingredient?

Lidocaine hydrochloride anhydrous, Epinephrine bitartrate.

Fresenius Kabi USA, LLC, NDC labeler code 63323. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Xylocaine MPF?

14 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Xylocaine MPF NDC 63323-489 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)63323-489Labeler and product segments. Claims need a package NDC.

Product NDC at billing width63323-0489Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
63323-489-17	63323048917	25 VIAL, SINGLE-DOSE in 1 TRAY (63323-489-17) / 10 mL in 1 VIAL, SINGLE-DOSE (63323-489-01)Marketed from Aug 12, 2010
63323-489-21	63323048921	5 VIAL, SINGLE-DOSE in 1 CARTON (63323-489-21) / 20 mL in 1 VIAL, SINGLE-DOSE (63323-489-03)Marketed from Aug 12, 2010
63323-489-27	63323048927	25 VIAL, SINGLE-DOSE in 1 TRAY (63323-489-27) / 20 mL in 1 VIAL, SINGLE-DOSE (63323-489-02)Marketed from Aug 12, 2010

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Xylocaine MPFSuffix: MPF
Generic name (nonproprietary): lidocaine hydrochloride,epinephrine bitartrate
Active ingredients: Lidocaine hydrochloride anhydrous — 20 mg/mLEpinephrine bitartrate — .005 mg/mL
Dosage form: Injection, Solution
Route: Epidural, Infiltration, Intracaudal, Perineural
Labeler: Fresenius Kabi USA, LLCNDC labeler code 63323
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 006488
Marketing start: Aug 12, 2010
Listing expires: Dec 31, 2026
Other FDA classes: Adrenergic alpha-Agonists (Mechanism)Adrenergic beta-Agonists (Mechanism)Amides (Chemical structure)Catecholamines (Chemical structure)Local Anesthesia (Physiologic effect)
Identifiers: Product ID 63323-489_ea480a68-5927-4278-9deb-2956961da428SPL ID ea480a68-5927-4278-9deb-2956961da428SPL set ID ba082c2f-64f4-419d-9c88-74f203316e17RxCUI 1010033, 1010035, 1010671, 1010673, 1010688, 1010692, 1010745, 1010749, 1010751, 1010755, 1010759, 1010763, 1010900, 1010902, 1737343, 1737345, 1737562, 1737563, 1737566, 1737567, 1737568, 1737569, 1737570, 1737571, 1737757, 1737758, 1737761, 1737762, 1867938, 1867940, 1867943, 1867944, 1867992, 1867993, 1867996, 1867997, 1868028, 1868029UNII 30Q7KI53AK, EC2CNF7XFPUPC 0363323484576, 0363323485016, 0363323483036, 0363323487072, 0363323486013, 0363323495091, 0363323488079, 0363323489021, 0363323495046, 0363323491017, 0363323492045, 0363323492090, 0363323482015, 0363323481018
Pharmacologic class: Amide Local Anesthetic; Antiarrhythmic; Catecholamine; alpha-Adrenergic Agonist; beta-Adrenergic Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N463323048917 followed by a unit qualifier and the quantity

Package 63323-0489-17. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 25, 2021.

Indications (excerpt from the label)

INDICATIONS AND USAGE Xylocaine (lidocaine HCl) Injections are indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 63323-489

What is NDC 63323-489?: 63323-489 is the product NDC for Xylocaine MPF, Lidocaine hydrochloride anhydrous 20 mg/mL; Epinephrine bitartrate .005 mg/mL injection, solution, listed with the FDA by Fresenius Kabi USA, LLC. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Xylocaine MPF (Lidocaine hydrochloride,Epinephrine bitartrate).
What is the active ingredient?: Lidocaine hydrochloride anhydrous, Epinephrine bitartrate.
Who is the labeler?: Fresenius Kabi USA, LLC, NDC labeler code 63323. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Xylocaine MPF?: 14 other product NDCs are listed under this name. See all Xylocaine MPF NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Xylocaine MPF NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Xylocaine MPFlidocaine hydrochloride	Lidocaine hydrochloride anhydrous 10 mg/mL	Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural	Fresenius Kabi USA, LLC	65219-810	65219-0810-02
Xylocaine MPFlidocaine hydrochloride	Lidocaine hydrochloride anhydrous 20 mg/mL	Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural	Fresenius Kabi USA, LLC	65219-812	65219-0812-02
Xylocaine MPFlidocaine hydrochloride	Lidocaine hydrochloride anhydrous 20 mg/mL	Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural	Fresenius Kabi USA, LLC	65219-814	65219-0814-05
Xylocaine MPFlidocaine hydrochloride	Lidocaine hydrochloride anhydrous 15 mg/mL	Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural	Fresenius Kabi USA, LLC	63323-493	63323-0493-9163323-0493-97
Xylocaine MPFlidocaine hydrochloride	Lidocaine hydrochloride anhydrous 20 mg/mL	Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural	Fresenius Kabi USA, LLC	63323-496	63323-0496-97
Xylocaine Mpf	Lidocaine hydrochloride anhydrous 10 mg/mL	Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural	HF Acquisition Co LLC, DBA HealthFirst	51662-1644	51662-1644-01
Xylocaine Mpflidocaine hydrochloride	Lidocaine hydrochloride anhydrous 5 mg/mL	Injection, SolutionInfiltration	HF Acquisition Co LLC, DBA HealthFirst	51662-1653	51662-1653-01
Xylocaine Mpflidocaine hydrochloride	Lidocaine hydrochloride anhydrous 10 mg/mL	Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural	HF Acquisition Co LLC, DBA HealthFirst	51662-1654	51662-1654-01
Xylocaine MPFlidocaine hydrochloride	Lidocaine hydrochloride anhydrous 10 mg/mL; Epinephrine bitartrate .005 mg/mL	Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural	Fresenius Kabi USA, LLC	63323-487	63323-0487-1763323-0487-3163323-0487-37
Xylocaine MPFlidocaine hydrochloride,epinephrine bitartrate	Lidocaine hydrochloride anhydrous 15 mg/mL; Epinephrine bitartrate .005 mg/mL	Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural	Fresenius Kabi USA, LLC	63323-488	63323-0488-1763323-0488-3163323-0488-37

All 15 Xylocaine MPF NDCs

Other NDCs under NDA 006488

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 006488
Product	Strength	Form · route	Labeler	Product NDC
Lidocaine Hci And Epinephrine	Lidocaine hydrochloride anhydrous 20 mg/mL; Epinephrine bitartrate .01 mg/mL	Injection, SolutionInfiltration, Perineural	HF Acquisition Co LLC, DBA HealthFirst	51662-1505
Lidocaine Hci And Epinephrine	Lidocaine hydrochloride anhydrous 20 mg/mL; Epinephrine bitartrate .01 mg/mL	Injection, SolutionInfiltration, Perineural	HF Acquisition Co LLC, DBA HealthFirst	51662-1506
Lidocaine Hci And Epinephrine With Epinephrine	Epinephrine bitartrate .005 mg/mL; Lidocaine hydrochloride anhydrous 20 mg/mL	Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural	HF Acquisition Co LLC, DBA HealthFirst	51662-1412
XYLOCAIN (LIDOCAINE HCl )xylocaine (lidocaine hcl )	Lidocaine hydrochloride anhydrous 10 mg/mL	Injection, SolutionInfiltration, Perineural	HF Acquisition Co LLC, DBA HealthFirst	51662-1587
Xylocainelidocaine hydrochloride and epinephrine	Lidocaine hydrochloride anhydrous 20 mg/mL; Epinephrine bitartrate .005 mg/mL	Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural	Henry Schein, Inc.	0404-9972
Xylocainelidocaine hydrochloride	Lidocaine hydrochloride anhydrous 10 mg/mL	Injection, SolutionInfiltration, Perineural	Henry Schein, Inc.	0404-9973
Xylocainelidocaine hcl	Lidocaine hydrochloride anhydrous 20 mg/mL	Injection, SolutionInfiltration, Perineural	Henry Schein, Inc.	0404-9974
Xylocainelidocaine hydrochloride, epinephrine bitartrate injection, solution	Lidocaine hydrochloride anhydrous 5 mg/mL; Epinephrine bitartrate .005 mg/mL	Injection, SolutionInfiltration, Perineural	Henry Schein, Inc	0404-9975
Xylocainelidocaine hydrochloride and epinephrine	Lidocaine hydrochloride anhydrous 20 mg/mL; Epinephrine bitartrate .01 mg/mL	Injection, SolutionInfiltration, Perineural	Henry Schein, Inc.	0404-9976
Xylocainelidocaine hydrochloride and epinephrine	Lidocaine hydrochloride anhydrous 10 mg/mL; Epinephrine bitartrate .01 mg/mL	Injection, SolutionInfiltration, Perineural	Henry Schein, Inc.	0404-9977
Xylocainelidocaine hydrochloride,epinephrine bitartrate	Lidocaine hydrochloride anhydrous 20 mg/mL; Epinephrine bitartrate .01 mg/mL	Injection, SolutionInfiltration, Perineural	A-S Medication Solutions	50090-6851
Xylocaine	Lidocaine hydrochloride anhydrous 20 mg/mL	Injection, SolutionInfiltration, Perineural	HF Acquisition Co LLC, DBA HealthFirst	51662-1590
Xylocaine	Lidocaine hydrochloride anhydrous 10 mg/mL	Injection, SolutionInfiltration, Perineural	HF Acquisition Co LLC, DBA HealthFirst	51662-1591
Xylocaine	Epinephrine bitartrate .01 mg/mL; Lidocaine hydrochloride anhydrous 10 mg/mL	Injection, SolutionInfiltration, Perineural	HF Acquisition Co LLC, DBA HealthFirst	51662-1622
Xylocaine	Lidocaine hydrochloride anhydrous 10 mg/mL	Injection, SolutionInfiltration, Perineural	HF Acquisition Co LLC, DBA HealthFirst	51662-1645
Xylocainelidocaine hydrochloride,epinephrine bitartrate	Lidocaine hydrochloride anhydrous 5 mg/mL; Epinephrine bitartrate .005 mg/mL	Injection, SolutionInfiltration, Perineural	Fresenius Kabi USA, LLC	63323-481
Xylocainelidocaine hydrochloride,epinephrine bitartrate	Lidocaine hydrochloride anhydrous 10 mg/mL; Epinephrine bitartrate .01 mg/mL	Injection, SolutionInfiltration, Perineural	Fresenius Kabi USA, LLC	63323-482
Xylocainelidocaine hydrochloride,epinephrine bitartrate	Lidocaine hydrochloride anhydrous 20 mg/mL; Epinephrine bitartrate .01 mg/mL	Injection, SolutionInfiltration, Perineural	Fresenius Kabi USA, LLC	63323-483
Xylocainelidocaine hydrochloride	Lidocaine hydrochloride anhydrous 5 mg/mL	Injection, SolutionInfiltration, Perineural	Fresenius Kabi USA, LLC	63323-484
Xylocainelidocaine hydrochloride	Lidocaine hydrochloride anhydrous 10 mg/mL	Injection, SolutionInfiltration, Perineural	Fresenius Kabi USA, LLC	63323-485

Showing 20 of 39.